what is glp 1 gip Dual GIP/GLP-1 receptor agonists: New advances for treating type-2 diabetes Glucagon-like peptide-1 - Wikipedia

OS also reduces tetrahydrobiopterin (BH4), a critical cofactor for eNOS, causing it to produce more ROS instead of NO, thereby amplifying endothelial injury (Figure 2), such as BH4 supplementation, NOX inhibitors, and lifestyle modifications (e.g., exercise, Mediterranean diet), aim to restore redox balance and endothelial function, though their efficacy varies by HTN stage and comorbidities

Predrag Sikiric at the University of Zagreb

There is no quality assurance, no batch testing to pharmaceutical standards, and no clinical oversight when you are administering them on your own

The most common side effects are G.I